|
HS Code |
202283 |
| Productname | Boc-D-Phe-OSu |
| Casnumber | 88303-62-8 |
| Molecularformula | C21H22N2O6 |
| Molecularweight | 398.41 |
| Purity | ≥98% |
| Appearance | White to off-white powder |
| Meltingpoint | 123-127°C |
| Storagetemperature | 2-8°C |
| Solubility | Soluble in DMF, DMSO, dichloromethane |
| Synonyms | N-[(1,1-Dimethylethoxy)carbonyl]-D-phenylalanyl N-succinimidyl ester |
| Application | Peptide synthesis |
| Opticalrotation | [α]D20 = -53° to -59° (c=1, DMF) |
As an accredited Boc-D-Phe-OSu factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-D-Phe-OSu is supplied in a 1-gram amber glass vial, sealed and labeled with product details and storage instructions. |
| Shipping | Boc-D-Phe-OSu is shipped in tightly sealed, moisture-proof containers under cool, dry conditions to ensure chemical stability. It is packaged according to standard regulations for organic chemicals, with labeling for safe handling. Temperature control (2–8°C) may be used to prevent degradation during transit. |
| Storage | Boc-D-Phe-OSu should be stored in a cool, dry, and well-ventilated area, away from moisture and direct sunlight. Keep the container tightly closed and preferably under an inert atmosphere, such as nitrogen or argon. Store at 2–8°C (refrigerated) to maintain stability and prevent decomposition. Avoid contact with incompatible substances such as strong acids and bases. |
Applications of Boc-D-Phe-OSu in Industrial ManufacturingBoc-D-Phe-OSu serves as a precision-activated amino acid derivative utilized in several highly regulated fine chemical and life science manufacturing workflows. Through consistent product quality and traceable production batches, we support downstream partners in areas such as peptide synthesis, pharmaceutical intermediates, diagnostic reagent formulation, and active cosmetic ingredient manufacturing. Below are key industrial applications, each with tailored industrial process and compliance considerations. 1. Peptide Therapeutics ManufacturingPeptide synthesis plants incorporate Boc-D-Phe-OSu as an N-protected, activated derivative for solid-phase coupling of D-phenylalanine residues. It functions specifically in automated and manual peptide synthesizer platforms operating under cGMP. Process engineers adjust input ratios based on resin loading and peptide sequence complexity, maximizing coupling efficiency while minimizing racemization. The protected D-amino acid residue is essential for achieving desired structural motifs, bioactivity, and resistance to enzymatic degradation in therapeutic peptides. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Small Molecule Pharmaceutical IntermediatesBoc-D-Phe-OSu is integrated as a chiral building block in API intermediate synthesis, particularly in the production of beta-lactam derivatives and non-natural amino acid drugs. The N-succinimidyl ester format allows rapid condensation under mild, anhydrous conditions, preserving chiral integrity and preventing side reactions. Process chemists leverage this reactivity profile to streamline multi-step API routes, reduce purification time, and support continual process validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Diagnostic Peptide Conjugate ProductionIn immunodiagnostic and analytical chemistry manufacturing, Boc-D-Phe-OSu acts as a key coupling agent for linker strategies requiring controlled orientation and reactivity. Operations teams exploit its N-terminal protection and activated ester functionality to enable selective immobilization of D-phenylalanine residues on solid-phase supports, beads, or protein carriers. These processes underpin high-specificity peptide-based reagents and calibrators used in automated diagnostic platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Cosmetic Active Ingredient FormulationIn the high-value cosmetic peptide market, R&D and production teams employ Boc-D-Phe-OSu during the synthesis of D-amino acid-based anti-aging, whitening, and cell-signaling peptides. The raw material's stability and reactivity under mild conditions align with regulatory limits on trace impurities and facilitate rapid incorporation into short-chain bioactive peptides. Production managers maintain close process control to prevent cross-contamination and conform to cosmetic-grade specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-D-Phe-OSu prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
On the production floor, clarity matters. Some years ago, the global surge in therapeutic peptide research demanded a higher standard from amino acid derivatives. Our teams saw how the wrong activated ester slows a project or leaves side-products behind. Laboratories don’t just want another building block—they want process confidence. In every batch of Boc-D-Phe-OSu we manufacture, quality starts with the incoming raw materials and follows through skilled crystallization, filtration, and purity checks. This compound, N-(tert-Butoxycarbonyl)-D-phenylalanyl N-succinimidyl ester, remains a popular option in peptide synthesis, especially for solid-phase strategies and fragment couplings.
Our process uses only D-phenylalanine of defined optical rotation. We introduced stricter HPLC profiling after early customers noticed trace racemization in competitor lots. There’s a difference: subtle shifts in enantiomeric ratios can interfere with peptide chain assembly, reducing biological consistency downstream. We avoid this pitfall through both raw material control and shorter exposure to activating reagents, minimizing opportunities for side-reactions. This is not just a checkbox on the COA—it’s a guarantee born from repeated double-checks and pressure from our own QC chemists.
Handling difficulty leads to schedule overruns. So, reliable physical behavior is not just cosmetic—it's part of working smoothly in the lab. Boc-D-Phe-OSu comes as a pale, crystalline powder, offering low clumping and easier dissolution in common organic solvents such as DMF, DCM, and acetonitrile. Granule size distribution receives attention on every batch. Fewer fines and predictable particle sizing reduce weighing errors on precision balances—a request echoed by clients scaling up to multi-hundred-gram runs.
We've listened to feedback from contract manufacturers who pointed out how moisture sensitivity can hit yield. To address this, we adapted our final drying protocols. Every lot receives both Karl Fischer moisture analysis and repeat FTIR confirmation before packing. Product leaves our facility in vacuum-sealed, lined containers, not in flexible plastic bags, blocking out environmental humidity for weeks. It’s one of the ways we stop product complaints before they start.
The peptide world offers several activated esters and protected phenylalanines. Why do process chemists still ask for Boc-D-Phe-OSu when alternatives exist? The answer comes down to selectivity in activation, clean coupling reactions, and storage stability.
NHS-activated esters like our OSu-format offer superior reactivity toward free amines compared to mixed anhydrides or acid chlorides. Side reactions, such as diketopiperazine formation, drop to trace levels, especially in solid-phase systems built on polystyrene supports. Boc protection, compared to Fmoc, brings resistance to basic media, so sequences with acid-labile residues hold up better. We maintain the D-configuration without DL-mixing through prompt post-synthesis handling and immediate isolation, preventing racemization even as the ester forms. Competing suppliers favor speed over optical purity—a short-term gain, long-term headache for purity profiles.
Users comparing OSu esters with OBt or Opfp forms have pointed out cost or safety limitations in the latter. On paper, hydroxybenzotriazole-activated analogs look attractive, but environmental safety regulations keep tightening on benzotriazole handling and waste. Our Boc-D-Phe-OSu sidesteps these issues, supported by a simpler waste stream. Both pharmaceutical scale clients and academic researchers prefer it for these reasons.
Inside lab diaries, the same notes appear—clean coupling steps, saved time, lower need for chromatographic purification. We've run peptide assembly test beds on both solid and solution-phase platforms in our own in-house lab. Boc-D-Phe-OSu consistently yields high-purity products after minimal workup, thanks to minimized side-product formation. The NHS leaving group departs without sticky by-products, making post-reaction washes quick. No stubborn residues mean fewer column cleanouts and more reliable automation. Even with manual batch processing, operators notice the lower odor compared to some acyl chloride solutions.
In combinatorial peptide chemistry, where speed wins contracts, the uniformity of Boc-D-Phe-OSu activation brings confidence to high-throughput setups. Failures due to incomplete couplings have dropped for manufacturers who switched from in situ mixed anhydride approaches. We’ve validated this internally and from customer reports—less need to repeat steps means saved reagents, time, and staff hours.
Large-scale need and customization drive our technical support. Early on, some surfaced challenges: suppliers delivered inconsistent lots or missed key documentation on impurity profiles. For our manufacturing, we doubled down on process documentation, real-time analytics, and batch-by-batch full spectrum NMR confirmation. The scale-up process doesn't just demand chemistry knowledge; it requires logistical foresight—drying step controls and inert atmosphere face greater challenges in multi-kilogram lots versus bench scale. Our answer is modular, closed reactors flushed with dry nitrogen, preventing water ingress at every turn.
Customers pushed us for lower trace metal residues after their own audits revealed catalyst carryover from other suppliers. We responded with full ICP-MS scans of every batch. No lot leaves our plant with unexplained peaks—our technical files include full decomposition data, detected trace elements, and optical rotation confirmation. Chemists on-site at client facilities tell us that detailed logs mean less downtime during regulatory audits. This mutual learning helps improve quality documentation both ways and strengthens the supply chain.
It’s easy to focus on coupling efficiency and forget shelf life. Raw inventories can sit for months before project greenlights. Our experience with Boc-D-Phe-OSu has shown solid stability when kept in its original sealed containers away from sunlight and heat. Accelerated aging studies show minimal decomposition, giving operators leeway during unpredictable delays. We run routine requalification analyses for clients with slow-moving stock, supplying fresh COA data on request.
Some peptide labs run longer reaction times using mild conditions, which puts the focus on stability under gentle mixing or cooling. We’ve had teams push Boc-D-Phe-OSu through 24-hour room temperature couplings and verify, by HPLC, consistent results without breakdown into unwanted side-products. That resilience in storage and synthesis conditions means less waste and fewer headaches around batch revalidation.
We work shoulder-to-shoulder with researchers trying new coupling agents, solvent systems, or on-resin modifications. Some test microwave-driven synthesis or unusual backbone linkers. Boc-D-Phe-OSu adapts well, offering fast dissolution and high recovery even under modified solvent regimes. We field support and troubleshooting questions directly from bench chemists working on cyclic peptides, peptidomimetics, and constrained analog syntheses. Our own process engineers feed back their successful optimizations—altered addition rates, more reliable pH control during activation, smarter scavenger choices for byproduct removal. Nothing beats real-world lab experience.
We don't just respond to customer needs; sometimes we see trends early. As green chemistry pushes for solvent minimization, we've engineered procedures for Boc-D-Phe-OSu that cut organic solvent consumption while holding yields steady. Direct input from pilot projects keeps us responsive to process chemistry’s shifting landscape. Application chemists now look for suppliers who engage, learn, and actually support process development, instead of just shipping boxes.
Over time, it becomes clear how much supply chain trust shapes project outcomes. Unplanned downtime traced back to a flawed reagent costs more than just time; it undermines confidence and puts project goals at risk. We’ve partnered with both large pharmaceutical developers and single-group academic labs. Their feedback shapes our continuous improvement process. On several occasions, labs switching from other suppliers reached out to relay improvements in yield, ease of purification, and consistent analytical signatures when adopting our Boc-D-Phe-OSu.
Chemists rarely praise product experience unless there’s a meaningful shift in routine—fewer failed couplings, less time spent chasing small impurities, or improved stability between batch productions. Several groups noticed fewer byproduct peaks on LC-MS, which lines up with our own control studies. In one large multi-center peptide initiative, process managers documented reduced batch failures after standardizing on our OSu-activated ester. Trust grows with each reliable delivery.
Sustainability in the fine chemicals world moves forward more slowly than many would like, but progress is possible. On our lines, hazardous solvent recycling and improved waste handling cut environmental impact. Boc-D-Phe-OSu production, by design, avoids reagents known for long-lived environmental hazards. Ongoing process optimization means smaller energy footprints and better recovery of process solvents. Regulatory audits have led us to cleaner exhaust filtration and more transparent batch logs. Open dialogue with regulatory and environmental teams means we anticipate tighter rules, not just react to them.
Clients facing their own EHS targets ask for full traceability and sustainable production plans. We deliver batch records that detail each upstream input and energy use, allowing for full supply chain audits. As pharmaceutical partners face higher scrutiny, our ongoing commitment to safer chemistry and transparency brings measurable value. We welcome discussions on greener coupling agents and alternate protection strategies as the field progresses.
Science never stops. Peptide coupling remains an evolving field, and research timelines keep tightening. We know from experience that process improvements come from close collaboration between supplier and customer. Direct input from researchers at the bench shapes our workflow, from improved packing protocols to better technical data packages. Feedback loops involve more than forms—they lead to upgraded SOPs and sometimes entirely new product variants at the customer’s request.
By making our senior chemists accessible to end-users, troubleshooting takes place on a level playing field. We conduct root-cause analysis on site when clients report a problem, not just from afar. Through participation in consortia and research initiatives worldwide, we remain at the front edge of what peptide chemists require. Boc-D-Phe-OSu will remain a cornerstone product as long as users value both quality and supplier engagement.
Trust in a chemical building block only comes after repeated, consistent performance. Boc-D-Phe-OSu, as we manufacture it, delivers on the demands of modern peptide synthesis without compromise. Stringent controls over optical purity, dried and contamination-free handling, and full transparency in analytical data let users focus on research—not on remediation. From milligram to multi-kilogram runs, from startup labs to production-scale facilities, Boc-D-Phe-OSu keeps processes moving forward.
Every successful peptide project depends on confidence in each ingredient. Building this confidence takes more than documentation; it takes a history of listening and responding to users’ real pain points. Our approach blends deep chemical expertise with real-world manufacturing discipline, offering not just a reagent but a long-term partnership in your lab or plant. In a world where peptide synthesis grows more complex, reliability and experience set us apart. Boc-D-Phe-OSu represents our commitment to helping you achieve the peptide targets of tomorrow, today.